The show's creator (Oppenheimer) and its newest star (Ellis) tell PEOPLE that "it's strange that it isn't strange" to work ...

Oppenheimer started coverage of Dianthus Therapeutics (NASDAQ:DNTH) with an outperform rating, citing the market potential of ...

Oppenheimer analyst Scott Schneeberger maintained a Buy rating on XPO (XPO – Research Report) today and set a price target of $140.00.

Oppenheimer has recently initiated Cadence Design Systems Inc (CDNS) stock to Underperform rating, as announced on September 25, 2024, according to Finviz. Earlier, on August 6, 2024, Piper Sandler ...

Oppenheimer analyst Ian Zaffino maintained a Buy rating on Talen Energy Corp (TLN – Research Report) today and set a price target of ...

Derek Hunt, who inherited the adjoining Sable Ranch and Rancho Maria from his grandfather, Frank Vacek, has put them up for ...

Real life couple, Tom Ellis and Meaghan Oppenheimer got candid on how it was to work “together” on the romantic television ...

We look at prior dramatizations of this very complicated man—including one wherein J. Robert Oppenheimer played himself!—and examine why they worked or didn't. In the episode: ...

Cillian Murphy once shared his “Catholic guilt” for making $10 million from Christopher Nolan’s Oppenheimer, admitting he ...

BridgeBio Pharma BBIO) stock received a Perform rating from Oppenheimer on market challenges to its late-stage assets acoramidis and infigratinib. Read more here.

After playing multiple supporting roles in Christopher Nolan films, Cillian Murphy delivered a smashing performance playing ...

The acclaimed documentarian discusses his first narrative feature and shares some strong words about the upcoming ...